Skip to main content
Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model

Fig. 4

a Cell cycle analysis of HCT 15 cells treated with control (PBS), celecoxib (IC50), empty liposomes (equivalent to volume of liposomal celecoxib), and liposomal celecoxib (IC50) for 48 h. M1-Sub-G1 Phase, M2-G0/G1 Phase, M3-S Phase, and M4-G2/M Phase. b DAPI nuclear staining of HCT 15 cells treated with control, free celecoxib (IC50), empty liposomes (equivalent to volume of liposomal celecoxib), and liposomal celecoxib (IC50) for 48 h (epi-fluorescence microscopic image at ×20 and scale bars, 10 μm). DNA fragmentation and apoptosis are marked with arrows

Back to article page